(Press-News.org) DALLAS, May 26, 2015 - A vaccine may one day help lower blood pressure for up to six months, according to new research in the American Heart Association's journal Hypertension.
The study in rats may eventually provide a novel alternative to treat high blood pressure in people, who would not need to take a pill everyday.
"The potential of a vaccine for hypertension offers an innovative treatment that could be very effective for the control of non-compliance which is one of the major problems in the management of hypertensive patients," said Hironori Nakagami M.D., Ph.D., study co-author and professor at Osaka University in Japan.
Researchers have designed a DNA vaccine that targets angiotensin II ? a hormone that raises blood pressure by causing blood vessels to constrict. This narrowing can increase your blood pressure and force your heart to work harder.
In the study, researchers immunized hypertensive rats three times at two-week intervals with needleless injections. The vaccine not only lowered blood pressure for up to six months, but also reduced tissue damage to the heart and blood vessels associated with hypertension. There were no signs of damage to other organs such as the kidney or liver.
The DNA vaccine works similar to common ACE inhibitor blood pressure medications which help blood vessels relax and open up, which, in turn, lowers blood pressure. Other types of vaccines have been tested for hypertension (e.g. a peptide vaccine), but didn't have lasting effects and some had undesirable side effects.
The ultimate goal of an anti-hypertensive vaccine is to achieve perfect blood pressure control by improving drug compliance through the vaccine. In addition, in the developing countries like Africa and south Asia, anti-hypertensive drugs such as ARB (angiotensin receptor blockade) are expensive. A DNA vaccine may provide cheaper and effective anti-hypertensive treatments in such countries, researchers said.
"Further research on this DNA vaccine platform, including increasing the longevity of blood pressure reduction, may eventually provide a new therapeutic option to treat hypertensive patients," Nakagami said.
The technology can also be applied to generate other vaccines.
INFORMATION:
Co-authors are Hiroshi Koriyama M.D., Ph.D; Futoshi Nakagami; M.D., Ph.D; Mariana Kiomy Osako, Ph.D; Mariko Kyutoku, Ph.D; Munehisa Shimamura M.D.; Ph.D; Hitomi Kurinami M.D., Ph.D; Tomohiro Katsuya M.D., Ph.D; Hiromi Rakugi M.D., Ph.D; and Ryuichi Morishita M.D., Ph.D. Author disclosures are on the manuscript.
Additional Resources:
Learn about high blood pressure
Follow AHA/ASA news on Twitter @HeartNews.
For the updates and new science from the Hypertension journal follow @HyperAHA.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.
A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours, a landmark clinical trial has shown.
It is the first time that a phase III trial of viral immunotherapy has definitively shown benefit for patients with cancer.
The trial was led in the UK by researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, and involved 64 research centres worldwide including the University of Oxford.
Researchers randomised 436 patients ...
BOSTON -- Carbon monoxide is known by many as a poisonous gas that causes brain injury and other neurological symptoms, including memory loss and confusion. But a new study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) suggests the opposite may be true: When administered in small, carefully controlled amounts, carbon monoxide may actually protect the brain from damage following subarachnoid hemorrhage, a devastating stroke that results from bleeding in the brain.
Published online today in The Journal of Clinical Investigation (JCI), the new findings ...
WASHINGTON (May 26, 2015) -- The American College of Cardiology's National Cardiovascular Data Registry was the source of data for seven studies published in the first four months of 2015, including a study that identified possible overuse of anticoagulants in low-risk atrial fibrillation patients and research that found a relationship between operator experience and outcomes in certain patients after percutaneous coronary intervention or angioplasty.
CathPCI Registry Study Compares Outcomes of Sleep-Deprived vs. Non-Sleep-Deprived PCI Operators
Only a small number of ...
University of Florida researchers have identified a biomarker that shows the progression of Parkinson's disease in the brain, opening the door to better diagnosis and treatment of the degenerative disease.
By comparing brain images of Parkinson's patients to those of a control group over a year, an interdisciplinary team found that an area of the brain called the substania nigra changes as the disease advances. The findings provide the first MRI-based method to measure the disease's progression, which can inform treatment decisions and aid in identifying new therapies, ...
Seasonal influenza vaccination of children is likely to represent good short-term value for money in Thailand, according to a study published this week in PLOS Medicine. The study, led by Aronrag Meeyai of the Health Intervention and Technology Assessment Program and Mahidol University, Thailand, uses an age-structured model to estimate the health benefits and cost-effectiveness of flu vaccination among Thai children aged 2 to 17 years.
Many seasonal influenza vaccination programs target elderly people, who have the highest risk of dying as a result of an influenza infection. ...
Adherence to the Dietary Guidelines for Americans (DGA) is linked to lower death rates in a low-income population in southeastern US.
In a low-income population from the southeastern US, higher adherence to the Dietary Guidelines for Americans (DGA) was linked with 14%-23% lower mortality from cardiovascular disease, cancer, and other diseases, according to a study published by Wei Zheng and colleagues from Vanderbilt University, Nashville, USA, in this week's PLOS Medicine.
The researchers analyzed data from the Southern Community Cohort Study (SCCS), a study including ...
PITTSBURGH, May 26, 2015 - Researchers at the University of Pittsburgh School of Medicine have identified two new classes of RNAs that are closely associated with a protein known to be a prognostic biomarker for breast cancer and could play a role in progression of prostate cancer. Their findings were published in the June issue of the scientific journal RNA.
Levels of human Y-box binding protein 1 (YB-1), which is involved in many cellular functions, have been shown to correlate with drug resistance and poor patient outcomes in a variety of cancers. The observation that ...
CINCINNATI - Maxing out the inherently stressed nature of treatment-resistant breast cancer cells thwarts their adaptive ability to evolve genetic workarounds to treatment, a new study suggests.
Scientists from Cincinnati Children's Hospital Medical Center report their results May 26 in Science Signaling.
"We present an alternative generic strategy for cancer treatment, which is removing cancer cells' defenses against their own intrinsic stress," said Kakajan Komurov, PhD, lead author and a researcher at the Cancer and Blood Disease Institute at Cincinnati Children's. ...
The importance of the umbilical cord not only for the fetus but for newborn infants too was shown by Swedish researchers several years ago, in a study that received great international acclaim. In a follow-up study in the journal JAMA Pediatrics they have now been able to show an association between delayed cord clamping (DCC) and children's fine motor skills at the age of four years, especially in boys.
Several years ago, in a clinical study comprising 400 newborns, Dr. Ola Andersson and colleagues demonstrated that the risk of iron deficiency at the age of four months ...
Racial stereotypes and expectations can impact the way we communicate and understand others, according to UBC research.
The new study, published in the Journal of the Acoustical Society of America, highlights how non-verbal "social cues" - such as photographs of Chinese Canadians - can affect how we comprehend speech.
"This research brings to light our internal biases, and the role of experience and stereotypes, in how we listen to and hear each other," says Molly Babel, the paper's lead author and an assistant professor with UBC's Department of Linguistics.
One of ...
